Clinical Trials Logo
  1. Home
  2. Drug Dependence
  3. NCT04709016

Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME — CONSUME  

Drug Dependence Clinical Trial

Official title:
The Use of Chemsex (Drug Use in a Sexual Context) Among MSM (Men Who Have Sex With Men) and Transgender People in France, Whether or Not Taking PrEP, and Its Impact on PrEP Adherence

Clinical Trial Summary

This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual orientation. The data are collected by self-questionnaire evaluating the consumption of Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of addiction treatment, the history of STIs (sexually transmitted infections) and adherence to PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used in the PREVENIR study).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04709016
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase
Start date March 18, 2021
Completion date March 25, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT02564341 - Targeting Effective Analgesia in Clinics for HIV - Intervention N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT00593463 - Drug Discrimination in Methadone-Maintained Humans Study 1 Phase 1
Completed NCT03678051 - CBT4CBT for Women in Residential Treatment for Substance Use Disorders N/A
Recruiting NCT04003948 - Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification Phase 2
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT01449981 - Development and Testing of Adolescent Twelve-Step Facilitation N/A
Completed NCT00183118 - Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment) Phase 1/Phase 2
Completed NCT00047866 - Brain Function in Response to Motivational Stimuli N/A
Recruiting NCT03333460 - Transcranial Magnetic Stimulation for Cocaine Addiction N/A
Completed NCT02124980 - Automated Recovery Line for Medication Assisted Treatment N/A
Terminated NCT00975416 - Oxytocin and Cognitive Behavioral Therapy in Drug Dependence Phase 4
Completed NCT00265512 - LINK: Aftercare Monitoring Project N/A
Completed NCT00706901 - Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans N/A
Completed NCT02656745 - Clinical Trial of Smoking Cessation Mobile Phone Program N/A
Withdrawn NCT00675532 - Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol). N/A
Active, not recruiting NCT03539575 - CB1R in Synthetic Psychoactive Cannabinoids N/A
Completed NCT01246401 - Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations Phase 1/Phase 2
Completed NCT01096550 - Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans N/A